Hypoxia-inducible factor 1-alpha gene G-quadruplex (HIF1A G4)

The Hypoxia-inducible factor 1-alpha gene G-quadruplex (HIF1A G4) is a non-canonical, four-stranded nucleic acid structure located within the promoter or 5'-untranslated region (UTR) of the HIF1A gene (Journal of the American Chemical Society, 2014). These structures form from guanine-rich DNA or RNA sequences and are stabilized by Hoogsteen hydrogen bonding, acting as a molecular switch to regulate gene expression (PubMed, 2015). Biologically, the stabilization of this G-quadruplex suppresses the transcription or translation of the HIF-1 alpha protein, which is the master regulator of cellular responses to low oxygen levels (Cancer Research, 2004). In many solid tumors, HIF-1 alpha is pathologically overexpressed, driving critical processes such as angiogenesis, metabolic reprogramming toward glycolysis, and metastasis (NCBI, 2025). Therapeutic interventions utilize small-molecule ligands designed to bind and stabilize the G-quadruplex, thereby effectively reducing HIF-1 alpha protein levels and inhibiting tumor growth (Journal of Medicinal Chemistry, 2013). While targeting this structure offers a specialized approach to cancer therapy, achieving high selectivity over other genomic G-quadruplexes remains a significant clinical challenge (PubMed, 2015).

Other names

HIF-1 alpha promoter G-quadruplexHIF1A G4HIF-1 alpha 5'-UTR G-quadruplexHypoxia-inducible factor 1-alpha G-quadruplex

Drugs target this molecule by binding to and stabilizing the G-quadruplex structure within the HIF1A promoter or 5'-UTR. This stabilization physically blocks the recruitment of transcription factors (such as AP2) or inhibits the progression of the transcriptional/translational machinery, leading to decreased expression of the HIF-1 alpha protein (Journal of the American Chemical Society, 2014; Cancer Research, 2004).